)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
PExA
PExA (PEXA) investor relations material
PExA Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary28 Aug, 2026
Executive summary
Revenue for Q2 2026 was 82,800 SEK, down from 312,582 SEK in Q2 2025; H1 2026 revenue was 1,188,559 SEK, up from 312,581 SEK year-over-year.
Net loss after financial items improved to -1,246,669 SEK in Q2 2026 from -2,315,399 SEK in Q2 2025; H1 2026 net loss was -2,199,311 SEK, an improvement from -4,563,974 SEK year-over-year.
Major commercial milestone: signed an 18-month, 7.5 MSEK contract with a top-10 global pharma company for 10 PEXA 2.1 systems for an international IPF clinical study.
Strengthened financial position post-period with over 26 MSEK raised through oversubscribed rights and directed share issues.
Financial highlights
Q2 2026 net sales: 82,800 SEK (Q2 2025: 312,582 SEK); H1 2026: 1,188,559 SEK (H1 2025: 312,581 SEK).
Q2 2026 net loss: -1,246,669 SEK (Q2 2025: -2,315,399 SEK); H1 2026 net loss: -2,199,311 SEK (H1 2025: -4,563,974 SEK).
Cash and cash equivalents at June 30, 2026: 796,326 SEK (June 30, 2025: 1,683,318 SEK).
Equity ratio at period end: 53.0% (67.1%).
Cash flow from operations Q2 2026: -1,924,402 SEK; total cash flow Q2 2026: -3,021,396 SEK.
Outlook and guidance
Contract with global pharma provides recurring revenue and increased predictability for coming quarters.
Strengthened capital base enables execution of larger customer projects and continued platform development.
Ongoing expansion into biomarker discovery, PK/PD, and diagnostics with a focus on lung disease and early detection.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from PExA
- Q1 2026 saw strong sales growth, improved results, and key research orders, but more funding is needed.PEXA
Q1 2026 - Strategic refocus on lung cancer diagnostics, narrowed losses, and improved cash position.PEXAQ4 2025
- Q3 revenue up 41%, rights issue secures 9.9 MSEK for diagnostic expansion.PEXAQ3 2025
- Revenue up, losses narrowed, and a guaranteed rights issue launched to fund clinical expansion.PEXAQ2 2025
- Sales and earnings fell, but strong equity and new funding support global expansion and R&D.PEXAQ3 2024
- Revenue fell and losses increased, but new funding and scientific milestones support future growth.PEXAQ2 2024
- No Q1 revenue as PEXA pivots to clinical focus; funding needed amid strong tech validation.PEXAQ1 2025
- Revenue declined and losses deepened, but scientific and market momentum remain strong.PEXAQ4 2024
Next PExA earnings date
Q3 20266 Nov, 2026
PExA
Next PExA earnings date
Q3 20266 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage